Search details
1.
Anti-disialoganglioside antibody internalization by neuroblastoma cells as a mechanism of immunotherapy resistance.
Cancer Immunol Immunother
; 71(1): 153-164, 2022 Jan.
Article
in English
| MEDLINE | ID: mdl-34043024
2.
Circulating T cell subsets are associated with clinical outcome of anti-VEGF-based 1st-line treatment of metastatic colorectal cancer patients: a prospective study with focus on primary tumor sidedness.
BMC Cancer
; 19(1): 687, 2019 Jul 15.
Article
in English
| MEDLINE | ID: mdl-31307428
3.
Colony stimulating factor 1 receptor blockade improves the efficacy of chemotherapy against human neuroblastoma in the absence of T lymphocytes.
Int J Cancer
; 143(6): 1483-1493, 2018 09 15.
Article
in English
| MEDLINE | ID: mdl-29665011
4.
Phase I trial of dasatinib, lenalidomide, and temozolomide in children with relapsed or refractory central nervous system tumors.
J Neurooncol
; 138(1): 199-207, 2018 May.
Article
in English
| MEDLINE | ID: mdl-29427149
5.
Preservation of high glycolytic phenotype by establishing new acute lymphoblastic leukemia cell lines at physiologic oxygen concentration.
Exp Cell Res
; 334(1): 78-89, 2015 May 15.
Article
in English
| MEDLINE | ID: mdl-25845499
6.
Lenalidomide overcomes suppression of human natural killer cell anti-tumor functions by neuroblastoma microenvironment-associated IL-6 and TGFß1.
Cancer Immunol Immunother
; 62(10): 1637-48, 2013 Oct.
Article
in English
| MEDLINE | ID: mdl-23982484
7.
Anti-CCL2 antibody combined with etoposide prolongs survival in a minimal residual disease mouse model of neuroblastoma.
Sci Rep
; 13(1): 19915, 2023 11 14.
Article
in English
| MEDLINE | ID: mdl-37964011
8.
Combined immune checkpoint blockade increases CD8+CD28+PD-1+ effector T cells and provides a therapeutic strategy for patients with neuroblastoma.
Oncoimmunology
; 10(1): 1838140, 2021 01 04.
Article
in English
| MEDLINE | ID: mdl-33489468
9.
Initiation of immunotherapy with activated natural killer cells and anti-GD2 antibody dinutuximab prior to resection of primary neuroblastoma prolongs survival in mice.
J Immunother Cancer
; 8(2)2020 12.
Article
in English
| MEDLINE | ID: mdl-33428582
10.
Anti-CD105 Antibody Eliminates Tumor Microenvironment Cells and Enhances Anti-GD2 Antibody Immunotherapy of Neuroblastoma with Activated Natural Killer Cells.
Clin Cancer Res
; 25(15): 4761-4774, 2019 08 01.
Article
in English
| MEDLINE | ID: mdl-31068371
11.
Activated Natural Killer Cells in Combination with Anti-GD2 Antibody Dinutuximab Improve Survival of Mice after Surgical Resection of Primary Neuroblastoma.
Clin Cancer Res
; 25(1): 325-333, 2019 01 01.
Article
in English
| MEDLINE | ID: mdl-30232225
12.
Cancer-Associated Fibroblasts Share Characteristics and Protumorigenic Activity with Mesenchymal Stromal Cells.
Cancer Res
; 77(18): 5142-5157, 2017 09 15.
Article
in English
| MEDLINE | ID: mdl-28687621
13.
TGFßR1 Blockade with Galunisertib (LY2157299) Enhances Anti-Neuroblastoma Activity of the Anti-GD2 Antibody Dinutuximab (ch14.18) with Natural Killer Cells.
Clin Cancer Res
; 23(3): 804-813, 2017 Feb 01.
Article
in English
| MEDLINE | ID: mdl-27756784
14.
Tumor-associated macrophages promote neuroblastoma via STAT3 phosphorylation and up-regulation of c-MYC.
Oncotarget
; 8(53): 91516-91529, 2017 Oct 31.
Article
in English
| MEDLINE | ID: mdl-29207662
15.
Dimethyl sulfoxide potentiates death receptor-mediated apoptosis in the human myeloid leukemia U937 cell line through enhancement of mitochondrial membrane depolarization.
Leuk Res
; 30(1): 81-9, 2006 Jan.
Article
in English
| MEDLINE | ID: mdl-15998540
16.
Role of p53 in regulating constitutive and X-radiation-inducible CD95 expression and function in carcinoma cells.
Cancer Res
; 63(21): 7176-84, 2003 Nov 01.
Article
in English
| MEDLINE | ID: mdl-14612511
17.
Simian virus-40 infection inhibits DNA damage-induced enhancement of CD95 expression and function.
Oncogene
; 21(2): 190-7, 2002 Jan 10.
Article
in English
| MEDLINE | ID: mdl-11803462
18.
Growth and activation of natural killer cells ex vivo from children with neuroblastoma for adoptive cell therapy.
Clin Cancer Res
; 19(8): 2132-43, 2013 Apr 15.
Article
in English
| MEDLINE | ID: mdl-23378384
19.
Membrane-bound TRAIL supplements natural killer cell cytotoxicity against neuroblastoma cells.
J Immunother
; 36(5): 319-29, 2013 Jun.
Article
in English
| MEDLINE | ID: mdl-23719242
20.
Critical role of STAT3 in IL-6-mediated drug resistance in human neuroblastoma.
Cancer Res
; 73(13): 3852-64, 2013 Jul 01.
Article
in English
| MEDLINE | ID: mdl-23633489